CIO

JANUARY 3, 2024

Putting aside the fact this is an astronomically high adoption rate for a brand new technology, it’s also an indicator of how risky this space is. When assessing vendors, Rich Products looks at their technology, architecture, business value, and pragmatic perspective. There’s no clear leader in the market yet.”

Alliance 803

Alliance Due Diligence Pharmaceutical Technology 803

Evalueserve

DECEMBER 6, 2021

The following trends have resulted in an overall improvement in M&A sentiments in the industry vs 2020: Unprecedented levels of alliances in the R&D ecosystem as several major biopharma companies collaborated to effectively leverage their resources to stem innovation. Sponsor deals rebounded exceptionally.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

SEPTEMBER 10, 2024

Riley Securities. For example, at the June 2024 meeting of the European Alliance of Associations for Rheumatology (EULAR), Cabaletta reported that two of its initial CAR-T therapy patients had significant improvements: one is now drug-free, and the other is reducing steroid use.

Hospitals 52

Hospitals Pharmaceutical Travel Research 52